<DOC>
	<DOC>NCT00730860</DOC>
	<brief_summary>A RCT was conducted to elucidate whether the treatment outcome of HCC could be improved by RFA associated with postoperative TACE.</brief_summary>
	<brief_title>Treatment of Hepatocellular Carcinoma With Radiofrequency Ablation (RFA) Associated With Postoperative TACE</brief_title>
	<detailed_description>A randomized study was conducted to elucidate whether the outcome of hepatocellular carcinoma could be improved by radiofrequency ablation associated with postoperative transhepatic arterial chemoembolization.</detailed_description>
	<mesh_term>Carcinoma, Hepatocellular</mesh_term>
	<mesh_term>Liver Neoplasms</mesh_term>
	<criteria>patients with hepatocellular,confirmed by pathological examination patients with a live function test showed Child A or B Indocyanine green test showed less than 30％ after 15min,and the patients showed a tolerance of RFA and TACE Tumor stage is early period(according to Milan Standard),that is,the diameter of single node should be less than 5cm；the node of tumor should be less than 3 and the diameter less than 3cm. without metastasis in lymphnode or other organs written consent inform assigned preoperative examination showed malignant thrombosis in the first class branch of portal vein or hepatic vein or vena cava metastatic cancer of liver patients with a poor tolerance of RFA and TACE patients received other therapies.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>radiofrequency ablation</keyword>
	<keyword>Cancer of Liver</keyword>
	<keyword>postoperative</keyword>
	<keyword>transhepatic arterial chemoembolization</keyword>
	<keyword>prospective</keyword>
</DOC>